About
Cancer therapies
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Team (7)
Clinical Trials (42)
View allTotal Trials
42
As Lead Sponsor
36
As Collaborator
6
Total Enrollment
5,843
By Phase
PHASE1/PHASE2: 7PHASE3: 9PHASE1: 13PHASE2: 11NA: 1PHASE2/PHASE3: 1
By Status
COMPLETED: 25RECRUITING: 10UNKNOWN: 3ACTIVE_NOT_RECRUITING: 2TERMINATED: 2
Clinical Trials Pipeline42 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT07129382Lead Sponsor
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
PHASE1/PHASE2Recruiting
220 participants
Started: Sep 8, 2025 · Completed: Sep 18, 2027
NCT06947967Lead Sponsor
Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
PHASE3Recruiting
224 participants
Started: Aug 12, 2025 · Completed: Dec 31, 2032
NCT06902350Lead Sponsor
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
PHASE1Recruiting
102 participants
Started: May 21, 2025 · Completed: Apr 30, 2029
NCT06497985Lead Sponsor
A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
PHASE3Recruiting
430 participants
Started: Nov 27, 2024 · Completed: Sep 30, 2028
NCT06492915Lead Sponsor
Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2Recruiting
42 participants
Started: Aug 13, 2024 · Completed: Jul 1, 2026
Locations (1)
Headquarters
Shenzhen, China
Map
Loading map...